Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for July 2009.

Pharmaceutical Technology
Volume 33, Issue 7, pp. 90

Milestones

Acceleration Holds Open House

Acceleration (Lee's Summit, MO) held an open house at its Lee's Summit facility to demonstrate its manufacturing services, which comply with good manufacturing practice. The company now provides services such as filling powder in capsules and vials, clinical trial materials, primary and secondary clinical packaging, analytical-method development and validation, stability testing, release testing, controlled substances, potent-drug capabilities, warehousing, and global distribution.

Catalent Offers Printing Capabilities

Catalent Pharma Solutions (Somerset, NJ), a leading provider of outsourced services to the global pharmaceutical, biotechnology, and consumer health industries, has made sample kits available for its printed components business. The kits demonstrate Catalent's printing capabilities for various packaging solutions such as labels, folding cartons, flexible packaging, booklets, inserts, outserts, blister cards, and compliance-enhancing packaging alternatives.

"This convenient sample box was designed and printed by Catalent to demonstrate our in-house packaging design capabilities from our pre-press, graphics, and design center of excellence," said Brian McCarthy, vice-president of business development for printed components at the company. Catalent's printing services comply with current good manufacturing practice guidelines for healthcare packaging solutions.

Sentry Takes New Name

Sentry Logistic Solutions (Indianapolis, IN) changed its name to Sentry BioPharma Services to reflect its enhanced service offerings and market focus on addressing the increasingly sophisticated needs of its clients.

"We believe our new name better reflects our evolution into a contract biopharmaceutical service provider addressing labeling and packaging, supply-chain management, coordinated global distribution, and fulfillment services supporting high-value and stringently regulated legend drug products and materials," said Jennifer Marcum, Sentry's chief executive officer, in a press release.

New Distribution Partners for Ahura

Ahura Scientific (Wilmington, MA) a leader in rugged, ultracompact instruments for chemical identification and verification, is expanding its global presence with 10 new distribution partners in Europe, the Middle East, and Africa. Ahura Scientific chose companies with a strong understanding of customer demands and demonstrated success in serving their respective markets.

"Expanding our international channel partner network is highly strategic to Ahura Scientific's growth," said Doug Kahn, the company's CEO. "We selected these exclusive partners following a thorough assessment of their domain expertise, complementary product lines, business fundamentals, and reputation with customers to ensure that our partners are as enthusiastic and proactive in developing new markets as we are."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
11%
Protecting the supply chain
39%
Expedited reviews of drug submissions
11%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here